Han Yu Pharmaceutical: Signed a contract with Sansei Mandi for the commission production and supply of Simieguru peptide injection, etc.

HanYu Pharmaceutical announced on the evening of August 19 that the company had previously signed a "Simiglucinide Injection Cooperation Agreement" with Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd. As the domestic clinical trial of the company's Simiglucinide injection is currently in phase III clinical trial stage, with all subjects already recruited and stable dosing period reached, the company has signed a "Commissioned Production and Supply Agreement", "Drug Commissioned Production Quality Agreement", and "Supplementary Agreement" with Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd. according to the original agreement of the "Simiglucinide Injection Cooperation Agreement" to clarify matters related to production and supply after the product is approved for market.